reference/30197472

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30197472

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	840
issn	0140-6736
issueIdentifier	9590
pageRange	829-840
publicationName	Lancet (London, England)
startingPage	829
bibliographicCitation	Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007 Sep 08;370(9590):829–40. doi: 10.1016/s0140-6736(07)61303-8. PMID: 17765963.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23c48a22c1559d62c8edb76eccf008fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79f925c940994f84c68caba13c7d67b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15b6cd584c8296b6df63b113175d9540 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9103cb0af584bd6a7ac49205e205fae1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18afd05f3f2f1f9cb167a535308ca155 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0490-7465 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_815bd3eef4ba2ecc232623b96a61d2eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1958388daf82156fc21aa6c3cb14cf24 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61d5bc46fd4d97822dc9eafe1ea67194 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d00249fcfb524cc56ef53d11c416668 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd7ad54a449ab5f1de71a95639902544 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdaef5b7fe168954ae84029312155f88 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b787f0413999aea27f055cdc89a2936b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3ae25e1eaaf261a673b1a1666692bbb http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3825-4092 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d05d6d5fd3441cd803c7fddf08536ec4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9931-0580 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57a1be10dd45799e4bfc11b540a40e78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45c08ec2d1054ebff8aea4d01427ef99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_983e7c2ed3fb53ec10e2edb406ed9ed2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa3adc2f3482adabb575b55d86126ccc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f041dc928196cea6a53c59f057ce6afd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df1e94ccc316b41f2b0649231978b1ff
date	2007-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/17765963 https://doi.org/10.1016/s0140-6736%2807%2961303-8
isPartOf	https://portal.issn.org/resource/ISSN/0140-6736 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0129811 http://id.nlm.nih.gov/mesh/M0006624 http://id.nlm.nih.gov/mesh/M0011207 http://id.nlm.nih.gov/mesh/M0001456 http://id.nlm.nih.gov/mesh/M0001207
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D020913Q000627 http://id.nlm.nih.gov/mesh/D006973Q000188 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D004232Q000627 http://id.nlm.nih.gov/mesh/D000806Q000627 http://id.nlm.nih.gov/mesh/D007190Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000959Q000627 http://id.nlm.nih.gov/mesh/D003924Q000150 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D006973Q000209 http://id.nlm.nih.gov/mesh/D003924Q000503 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001794Q000187 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7671 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9585 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3702 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_360e2ece07507675dced80ba867d6dcd

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128685069 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128203001

Total number of triples: 76.